Edwards Lifesciences

GENEVA, Switzerland, September 13, 2010 - Edwards Lifesciences Corporation (NYSE:EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the U.S.

PARIS, May 25, 2010 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Martyn Thomas, M.D., reported that the Edwards SAPIEN transcatheter heart valve demonstrated promising one-year mortality rates for high-risk patients, many of whom were too sick to undergo traditional open-heart surgery.